Header Logo

Connection

FNU Shivani to Dipeptidyl-Peptidase IV Inhibitors

Back to Details
This is a "connection" page, showing publications FNU Shivani has written about Dipeptidyl-Peptidase IV Inhibitors.
FNU Shivani
Connection Strength
0.239
Dipeptidyl-Peptidase IV Inhibitors
  1. Triple oral therapy combining metformin, SGLT-2 and DPP-4 inhibitors versus dual therapy in type 2 diabetes mellitus: A systematic review and meta-analysis. Medicine (Baltimore). 2026 May 29; 105(22):e49050.
    View in: PubMed
    Score: 0.239
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.